drugset / Trial / NCT07699770
Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a multicenter, prospective, randomized, double-blind, placebo-controlled exploratory investigation conducted in China.
Timeline
- Start
- 2026-06-15
- Primary completion
- 2027-10-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK16149 | Unknown | 20 mg | — |
| Subject | HSK16149 | Unknown | 40 mg | — |